Muthulekha Swamydas

Cleveland Clinic Lerner College of Medicine

Papers

1

Total Citations

3

H-Index

1

About

Muthulekha Swamydas is a leading researcher in regenerative medicine and cellular therapy, with a primary focus on mesenchymal stromal cell (MSC) biology and biomanufacturing. Her most cited work, "Automation and Performance-Based Selection to Improve the Reproducibility of Mesenchymal Stromal Cell (MSC) Fabrication" (2024), addresses a critical bottleneck in the field: the variability and lack of standardization in MSC production. By integrating automated systems with functional performance metrics, Swamydas has pioneered methods that enhance the consistency, scalability, and clinical reliability of MSC-based therapies—a contribution that directly impacts the translation of these cells from bench to bedside. With over 3 citations in a short time, her work is gaining traction among researchers seeking robust manufacturing protocols. Her achievements underscore a commitment to bridging engineering and biology, offering practical solutions for reproducible cell fabrication. For students and researchers, Swamydas exemplifies how systematic innovation in process control can elevate the reproducibility and therapeutic potential of cellular products.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
AUTOMATION AND PERFORMANCE-BASED SELECTION TO IMPROVE THE REPRODUCIBILITY OF MESENCHYMAL STROMAL CELL (MSC) FABRICATION
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Cleveland Clinic Lerner College of Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago